Pharmaceutical Technology

DECEMBER 19, 2022

Initially, the companies signed a research collaboration and licensing agreement in 2016 to develop and assess up to two bispecific NK cell engagers. As per the deal, Sanofi will hold an option to include up to two further ANKET targets. On choosing the candidate, the company will oversee the complete development, production and marketing.

Development 264

Development Engineer Clinical Trials Clinical Trials 264

Pharmaceutical Technology

MAY 2, 2023

Bristol Myers Squibb (BMS) has exercised its opt-in rights for the first T cell receptor (TCR)-engineered T cell therapy (TCR-T) from Immatics. Immatics will receive $15m from the global license agreement and is in line for a further $490m in milestone payments for this candidate.

Licensing 130

Licensing Licensing Gene Editing Development 130

Pharmaceutical Technology

JANUARY 5, 2023

Under the multi-year strategic partnership, Prevail will detect and advance capsids, which are clinically translatable, along with its cargo to develop the transformative genetic medicines by using Capsida’s novel adeno-associated virus (AAV) engineering platform.

Gene Therapy 237

Gene Therapy Gene Development Engineer 237

BioTech 365

AUGUST 17, 2021

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement License allows Cellular Engineering Technologies to develop, manufacture and commercialize next generation stem cell lines using CRISPR/Cas9 technology DUBLIN & … Continue (..)

Engineer 40

Engineer Genomics Genome Licensing 40

Medical Xpress

NOVEMBER 22, 2024

A team of artificial intelligence engineers, in collaboration with a team of physicians from Penn State Heart and Vascular Institute, is working to develop novel algorithms for point-of-care, in-house use and for technology licensing.

Cardiology 105

Cardiology Engineer Doctor Doctors 105

Scienmag

AUGUST 24, 2020

A team of researchers at University of Toronto Engineering and University of Michigan have modified an enzyme from bacteria to promote regrowth of nerve tissue Credit: Hettiaratchi, O’Meara et al.,

Engineer 53

Engineer Bacteria Licensing Licensing 53

Scienmag

AUGUST 5, 2020

Announces exclusive licensing partnerships for proprietary regulatory T cell engineering technologies with Seattle Children’s Research Institute, Benaroya Research Institute and MIGAL Galilee Research Institute Credit: GentiBio, Inc. BOSTON, Mass., SEATTLE, Wash., and QIRYAT SHMONA, Israel, August 5, 2020 – GentiBio, Inc.,

Engineer 52

Engineer Development Licensing Licensing 52

BioTech 365

OCTOBER 19, 2021

Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs … Continue reading →

Gene Editing 40

Gene Editing Engineer Licensing Licensing 40

Pharmaceutical Technology

APRIL 28, 2023

EDIT-301 is made of patient-derived CD34+ haematopoietic stem and progenitor cells, which are edited using CRISPR at the gamma globin gene (HBG1 and HBG2) promoter sites using a proprietary engineered AsCas12a nuclease, per the company’s website. This increases the expression of fetal haemoglobin.

Gene Therapy 264

Gene Therapy Drugs Gene Gene Editing 264

Pharmaceutical Technology

JANUARY 4, 2023

Cell-engineering company MaxCyte has signed a strategic platform licence (SPL) with biotechnology company Catamaran Bio to support the chimeric antigen receptor (CAR)-NK cell therapy programmes. These CAR-NK cell therapies combine new functional attributes with the NK cells’ inherent cancer-fighting properties.

Engineer 130

Engineer Gene Therapy Gene Development 130

Pharmaceutical Technology

JUNE 21, 2023

Hemgenix works by dosing a patient with an engineered adeno-associated virus (AAV), containing the gene responsible for producing a protein called factor IX. Already a big player in haemophilia treatments, CSL licensed exclusive global rights to Hemgenix from gene therapy developers uniQure back in 2021.

Gene Therapy 246

Gene Therapy Gene Protein Sales 246

Scienmag

NOVEMBER 10, 2020

In a quest to create a one-stop telehealth solution, Ignis Health, which has developed a robust telehealth analytics platform, licenses a roadmap for telehealth implementation from the Medical University of South Carolina Credit: Medical University of South Carolina The Medical University of South Carolina and Ignis Health share a common goal – (..)

Licensing 58

Licensing Licensing Development Engineer 58

Pharmaceutical Technology

MAY 3, 2023

BrightPath Biotherapeutics and Artisan Bio have signed a research and licensing agreement to expedite the former’s allogeneic next-generation invariant natural killer T (iNKT) cell therapies to clinic. The company will also receive net sales milestones and royalties on future products.

Gene Therapy 130

Gene Therapy Gene Engineer Development 130

BioTech 365

JULY 26, 2021

ERS Genomics and Japan SLC Sign CRISPR/Cas9 License Agreement ERS Genomics and Japan SLC Sign CRISPR/Cas9 License Agreement Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models DUBLIN & SHIZUOKA, Japan–(BUSINESS WIRE)–ERS Genomics Limited, … Continue reading →

Genomics 40

Genomics Genome Licensing Licensing 40

BioTech 365

MARCH 9, 2021

ERS Genomics and Setsuro Tech Sign CRISPR/Cas9 License Agreement ERS Genomics and Setsuro Tech Sign CRISPR/Cas9 License Agreement Nobel prize winning CRISPR technology to be applied in development of genetically engineered cell and animal models DUBLIN & TOKUSHIMA, Japan–(BUSINESS WIRE)–ERS … Continue reading →

Genomics 40

Genomics Genome Licensing Licensing 40

Pharmaceutical Technology

MAY 25, 2023

Adalvo has entered a strategic licensing agreement with Swiss pharmaceutical company EQL Pharma for Mellozzan (melatonin) outside Europe and the US. Adalvo brings to the table its regulatory expertise and then will put its extensive commercial engine to work with a view of laying out a globalisation roadmap for Mellozzan.

Hormones 130

Hormones Engineer Containment Licensing 130

Pharmaceutical Technology

MARCH 23, 2023

Seagen will maintain its operations in the Seattle area and will leverage Pfizer’s protein-engineering capabilities to develop next-generation biologics. This figure derives from net product sales in addition to revenues gained from royalties and licensing agreements.

Licensing 147

Licensing Licensing Sales Trials 147

XTalks

MARCH 17, 2021

To address this, a research team of engineers and clinicians at Purdue designed an all-printed stretchable corneal sensor built into commercial disposable soft contact lenses. The technology has received a patent through the Purdue Research Foundation Office of Technology Commercialization and is now available for licensing.

Engineer 128

Engineer Research Licensing Licensing 128

BioTech 365

NOVEMBER 11, 2020

Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute CAMBRIDGE, Mass.–(BUSINESS

Licensing 40

Licensing Licensing Engineer 40

Pharmaceutical Technology

JULY 22, 2022

TX200 is a collection of autologous regulatory T cells (Tregs) that are engineered to express an HLA-A2 Chimeric Antigen Receptor (CAR) to prevent immune-mediated rejection in HLA-A2 mismatched kidney transplants from a living donor.

Medicine 130

Medicine Production Genomics Genome 130

BioTech 365

OCTOBER 15, 2020

Fourteen new patents expand worldwide protection of the unique beneficial designs of AlivaMab Mouse and AlivaMab antibodies, and Ablexis’ innovations in immunoglobulin transgene engineering SAN DIEGO–(BUSINESS WIRE)–Ablexis, LLC, a biopharmaceutical company focused on licensing its transgenic mouse platforms for antibody … Continue (..)

Engineer 40

Engineer Antibody Licensing Licensing 40

Scienmag

SEPTEMBER 15, 2020

of Energy Prometheus Fuels has licensed an ethanol-to-jet-fuel conversion process developed by researchers at the Department of Energy’s Oak Ridge National Laboratory. Credit: Carlos Jones/ORNL, U.S.

Licensing 53

Licensing Licensing Production Development 53

Scienmag

JUNE 28, 2021

University of Illinois at Urbana-Champaign and USNC will collaborate to license and construct next-generation micro modular reactor URBANA, Ill. Nuclear Regulatory Commission (NRC) to apply for a license to construct a research and test […].

Licensing 45

Licensing Licensing Research Engineer 45

Pharmaceutical Technology

DECEMBER 14, 2022

Under the deal, Merck will license its VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform. Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications.

Gene Therapy 130

Gene Therapy Gene Development Manufacturing 130

The Pharma Data

JANUARY 6, 2021

a leading global provider of immuno-oncology imaging agents, today announced it has signed a new multi-year, non-exclusive license with Pfizer Inc. ImaginAb will receive license fees and payments for manufacturing and other support. LOS ANGELES , Jan. 7, 2021 /PRNewswire/ — ImaginAb Inc. , No other terms were disclosed.

Licensing 52

Licensing Licensing Clinical Trials Clinical Trials 52

Drug Discovery Today

APRIL 22, 2020

Cambridge, UK, and Brisbane, CA, 21 April 2020 Mogrify Ltd (Mogrify®), a UK company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions, and Sangamo Therapeutics (Sangamo) (Nasdaq: SGMO), a genomic medicine company, today announced that they have executed a collaboration and exclusive license (..)

Licensing 40

Licensing Licensing Genomics Genome 40

pharmaphorum

MARCH 24, 2022

LifeMine has developed an industrialised, genomics-based discovery engine that it hopes will take a broad, systematic approach to identifying new compounds from fungi and screening them for activity against disease targets.

Medicine 105

Medicine Genomics Genome Engineer 105

XTalks

MARCH 19, 2025

Eneboparatide is engineered to bind with high affinity to a specific conformation of the PTH1R, essentially mimicking the hormones natural action. In doing so, it helps regulate calcium and phosphate more naturally, potentially limiting urinary calcium excretion and supporting kidney and bone health.

Trials 59

Trials Hormones Engineer Licensing 59

Pharmaceutical Technology

SEPTEMBER 22, 2022

The merged business will focus on the advancement of Charisma's cell therapy platform, which leverages engineered macrophages and monocytes to transform the way cancers and other serious ailments are treated. . Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Clinical Trials 130

Clinical Trials Clinical Trials Gene Therapy Engineer 130

pharmaphorum

APRIL 8, 2022

billion licensing agreement with Werewolf Therapeutics that adds its first immuno-oncology candidate. As it is in the very early stages Jazz’s licensing deal is heavily back-weighted, but does include $1.26 Jazz Pharma has bolstered its pipeline of cancer drugs through a $1.3 Image by Lukas Bieri from Pixabay .

Drugs 105

Drugs Immune Response Licensing Licensing 105

Scienmag

NOVEMBER 20, 2020

Credit: University of South Australia A key symptom of COVID-19 – oxygen saturation – is now being estimated remotely from a camera, thanks to research from University of South Australia engineers Professor Javaan Chahl, Dr Ali Al-Naji and their team of graduate students.

Engineer 52

Engineer Licensing Licensing Development 52

Scienmag

AUGUST 20, 2020

VA seeking companies to license, manufacture Credit: Dr. Scott Fuller/VA SACRAMENTO, Calif. – An ear, nose, and throat doctor has invented a simple mask design that significantly improves safety during aerosol-generating procedures of the head and neck.

Doctor 95

Doctor Doctors Licensing Licensing 95

BioPharma Reporter

APRIL 13, 2023

As part of a $1 billion deal forged in 2020, Biogen has exercised the option to license a treatment candidate for Alzheimerâs disease developed by the US biotech company Denali Therapeutics. The engineered antibody drug is designed to cross into the brain and break down harmful plaques better than approved antibodies can.

Antibody 52

Antibody Engineer Drugs Licensing 52

Scienmag

AUGUST 31, 2020

Startup has licensed butterfly wing-inspired technology to develop high-performing, affordable air purification systems The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A.

Engineer 40

Engineer Licensing Licensing Development 40

The Pharma Data

NOVEMBER 4, 2020

Ltd (“Juyou”), a biotechnology company that develops and sells medical and cosmetic skincare products, for the commercialization and development of Pliaglis ® in mainland China (the “License Agreement”). million and US$1.8 For additional information, please visit [link].

Licensing 40

Licensing Licensing Dermatology Production 40

Pharmaceutical Technology

FEBRUARY 16, 2023

New-age technologies such as IoT, big data analytics, and 5G, as well as trends such as software-as-a-service (SaaS), cloud licensing, new frameworks of software, and high-speed digital standards, will revolutionise the future of analysis, testing and measurement equipment.

Engineer 130

Engineer Manufacturing Containment Production 130

Pharmaceutical Technology

JANUARY 10, 2023

Boehringer Ingelheim has entered a strategic partnership and licensing agreement with 3T Biosciences for the discovery and development of next-generation cancer immunotherapies.

Gene Therapy 130

Gene Therapy Sales Gene Production 130